ES
Enavate Sciences Portfolio holdings
AUM
$177M
This Quarter Return
+44.71%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$177M
AUM Growth
+$177M
(+33%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Immunome
IMNM
$828M
| $44.3M | 25.12% |
4,768,583
| – | – |
|
|
SION
2
Sionna Therapeutics, Inc. Common Stock
SION
$1.09B
| $43M | 24.35% |
2,478,030
| – | – |
|
|
ZBIO
3
Zenas BioPharma, Inc. Common Stock
ZBIO
$674M
| $36.4M | 20.65% |
3,761,359
| – | – |
|
|
UPB
4
Upstream Bio, Inc. Common Stock
UPB
$923M
| $27M | 15.3% |
2,459,703
| – | – |
|
5
Compass Therapeutics
CMPX
$483M
| $20.2M | 11.47% |
7,788,150
| – | – |
|
6
CAMP4 Therapeutics Corporation Common Stock
CAMP
$30.6M
| $5.49M | 3.11% |
3,785,802
| – | – |
|